HEPATOCELLULAR CARCINOMA IN A NON-CIRRHOTIC PATIENT WITH SUSTAINED VIROLOGICAL RESPONSE AFTER HEPATITIS C TREATMENT

HEPATOCELLULAR CARCINOMA IN A NON-CIRRHOTIC PATIENT WITH SUSTAINED VIROLOGICAL RESPONSE AFTER HEPATITIS C TREATMENT

Chronic infection by hepatitis C virus (HCV) is one of the main risk factors for the development of liver cirrhosis and hepatocellular carcinoma. However, the emergence of hepatocellular carcinoma (HCC) in non-cirrhotic HCV patients, especially after sustained virological response (SVR) is an unusua...

Full description

Bibliographic Details
Main Authors:	Angelo Alves de MATTOS, Patrícia dos Santos MARCON, Fernanda Schild Branco de ARAÚJO, Gabriela Perdomo CORAL, Cristiane Valle TOVO
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2015-12-01
Series:	Revista do Instituto de Medicina Tropical de São Paulo
Subjects:	Hepatocellular carcinoma Hepatitis C Genotype 3 Sustained virological response Non-cirrhotic liver
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652015000600519&lng=en&tlng=en

Similar Items

Hepatocellular carcinoma in a woman with 34 weeks gestation and chronic hepatitis b
by: Sato-Espinoza, Karina, et al.
Published: (2021)

Hepatocellular carcinoma in a non‐cirrhotic liver with a tumor thrombus
by: Abid M. Sadiq, et al.
Published: (2021-09-01)

Radiofrequency ablation of surface v/s intraparenchymal hepatocellular carcinoma in cirrhotic patients
by: Yashwant Patidar, et al.
Published: (2017-10-01)

Usefulness of Pure Laparoscopic Hepatectomy for Hepatocellular Carcinoma in a Severely Cirrhotic Patient
by: Isamu Hosokawa, et al.
Published: (2013-07-01)

Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list
by: Patricia R. Bonazzi, et al.

Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
by: Seong Kyun Na, et al.
Published: (2019-09-01)

Research advances in risk factors for hepatocellular carcinoma in chronic hepatitis C patients with sustained virologic response
by: YANG Luxuan, et al.
Published: (2017-03-01)

In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
by: Bisha Ding, et al.
Published: (2019-07-01)

Therapy of chronic hepatitis C: Virologic response monitoring
by: Kuljić-Kapulica Nada, et al.
Published: (2010-01-01)

The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2
by: Sung Yong Han, et al.
Published: (2021-05-01)

Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy
by: Roberta D'Ambrosio, et al.
Published: (2015-08-01)

Bisegmentectomy 7–8 for Small-for-Size Remanant Liver for Cirrhotic Patients Under Right Hemi-hepatectomy With Hepatocellular Carcinoma: A Case-Matched Comparative Study
by: Xishu Wang, et al.
Published: (2021-07-01)

Association between insulin resistance and sustained virologic response in hepatitis C treatment, genotypes 1 versus 2 and 3: systematic literature review and meta-analysis
by: Marcela Pezzoto Laurito, et al.

Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance
by: Griffith AS, et al.
Published: (2018-05-01)

Hepatocellular carcinoma in a hepatitis C patient with sustained viral response and no fibrosis
by: James H. Tabibian, et al.
Published: (2009-01-01)

Cirrhotic cardiomyopathy and liver transplantation
by: Yu. O. Malinovskaya, et al.
Published: (2016-09-01)

Research advances in non-cirrhotic portal hypertension
by: ZHANG Bojing, et al.
Published: (2016-02-01)

Idiopathic non-cirrhotic portal hypertension and its causes
by: O.M. Vlasova
Published: (2018-02-01)

Cirrhotic liver explants: regenerative nodule, dysplasia and hepatocellular carcinoma occurrence Explantes de fígado por cirrose: ocorrência de nódulo regenerativo, displasia e carcinoma hepatocelular
by: Daniel Dutra Romualdo da Silva, et al.
Published: (2005-12-01)

Hepatitis C virus: virology and life cycle
by: Chang Wook Kim, et al.
Published: (2013-03-01)

Prevalence of glucose intolerance in cirrhotics and risk factors predicting its progression to diabetes mellitus
by: Pavan Hanchanale, et al.
Published: (2017-01-01)

Diastolic dysfunction characterizes cirrhotic cardiomyopathy
by: Piyush O. Somani, et al.
Published: (2014-11-01)

Serum proteome predicts virological response in chronic hepatitis C genotype 1b patients treated with pegylated interferon plus ribavirin
by: Yi-Hao Yen, et al.
Published: (2015-07-01)

Hepatitis C virus genotype affects survival in patients with hepatocellular carcinoma
by: Hye Kyong Park, et al.
Published: (2019-08-01)

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
by: O. D. Olisov, et al.
Published: (2018-09-01)

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
by: Nelson Cheinquer, et al.

To what extent the DW-MRI and ADC value can be used in assessment of hepatic focal lesions in cirrhotic patients
by: Moustafa Abdel Kader, et al.
Published: (2017-12-01)

Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
by: Khaled Mohieldeen, et al.
Published: (2021-09-01)

Non-cirrhotic portal fibrosis
by: Venkatesan Mukta, et al.
Published: (2014-01-01)

An unfortunate failure: multifocal hepatocellular carcinoma in a non-cirrhotic patient with chronic hepatitis C treated with ledipasvir/sofosbuvir
by: Megan Sue Soliman, et al.
Published: (2018-05-01)

Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin
by: Ng KJ, et al.
Published: (2016-08-01)

Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil
by: R.S.M. Alencar, et al.
Published: (2008-03-01)

Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma
by: Abdel-Rahman N. Zekri, et al.
Published: (2014-01-01)

Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites
by: Atsushi Hosui, et al.
Published: (2021-01-01)

Cirrhotic Cardiomyopathy: Another Case of a Successful Approach to Treatment of Hepatorenal Syndrome
by: Luis Otávio Mocarzel, et al.
Published: (2016-10-01)

Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort
by: Tiago Pereira Guedes, et al.
Published: (2019-10-01)

Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin
by: Pei-yuan Su, et al.
Published: (2016-07-01)

Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis
by: Chang Seok Bang, et al.
Published: (2017-04-01)

Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment
by: Ming-Tsung Lin, et al.
Published: (2021-01-01)

Evaluation of Echocardiographic Findings in Cirrhotic Patients
by: M Seidian, et al.
Published: (2005-10-01)